Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Scientific Officer

Chief of Staff, CCO & GC

Chief Financial Officer

See Remarks

CEO and President

see remarks

Chief of Sustainable Supply

Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The company also develops Crofelemer, which is in Phase 3 clinical trial for or prophylaxis of diarrhea in adult cancer patients, and to address rare/orphan disease indications, including Short bowel syndrome with intestinal failure and/or congenital diarrheal disorders; supportive care for diarrhea relief in inflammatory bowel diseases; diarrhea-predominant irritable bowel syndrome; and for idiopathic/functional diarrhea. In addition, it develops NP-300, a second-generation proprietary anti-secretory antidiarrheal drug for symptomatic relief and treatment of moderate-to-severe diarrhea; and Canalevia, an oral plant-based drug candidate to treat chemotherapy-induced diarrhea in dogs and exercise-induced diarrhea in dogs. The company was founded in 2013 and is headquartered in San Francisco, California.

Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with ...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-05	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2024-04-05	Premium	acquired	Premium	Premium	Premium	Chief of Staff, CCO & GC
2024-04-05	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2024-04-05	Premium	acquired	Premium	Premium	Premium	See Remarks
2024-04-05	Premium	acquired	Premium	Premium	Premium	CEO and President
2023-08-14	Premium	acquired	Premium	Premium	Premium	see remarks
2023-08-14	Premium	acquired	Premium	Premium	Premium	CEO and President
2023-08-14	Premium	acquired	Premium	Premium	Premium	-
2023-08-14	Premium	acquired	Premium	Premium	Premium	-
2023-08-14	Premium	acquired	Premium	Premium	Premium	-
2023-08-14	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2023-08-14	Premium	acquired	Premium	Premium	Premium	Chief of Staff, CCO & GC
2023-08-14	Premium	acquired	Premium	Premium	Premium	-
2023-08-14	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2023-07-01	Premium	acquired	Premium	Premium	Premium	-
2023-05-17	Premium	acquired	Premium	Premium	Premium	-
2023-05-17	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2023-05-17	Premium	acquired	Premium	Premium	Premium	Chief of Staff, CCO & GC
2023-05-17	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2023-05-17	Premium	acquired	Premium	Premium	Premium	Chief of Sustainable Supply
2023-05-17	Premium	acquired	Premium	Premium	Premium	-
2023-05-17	Premium	acquired	Premium	Premium	Premium	-
2023-05-17	Premium	acquired	Premium	Premium	Premium	CEO and President
2023-04-05	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2023-04-05	Premium	acquired	Premium	Premium	Premium	Chief of Staff, CCO & GC

JAGX - Jaguar Health Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for JAGX